Xoten CA 75mg/20mg/75mg Tablet
Images are for reference. Actual packaging may vary.
Strip of 15 tablets • TabletPrescription requiredSchedule H
Xoten CA 75mg/20mg/75mg Tablet
Aspirin (75mg) + Rosuvastatin (20mg) + Clopidogrel (75mg)
₹222.20
Strip of 15 tablets • Tablet
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Aspirin 75 mg
+2 more active ingredients
How It Works
Aspirin irreversibly inhibits COX-1 and COX-2 enzymes, leading to decreased production of thromboxane A2 and prostaglandins.
Clopidogrel irreversibly inhibits the P2Y12 component of ADP receptors on platelets, preventing platelet activation and aggregation.
Rosuvastatin inhibits HMG-CoA reductase, decreasing cholesterol synthesis in the liver and increasing LDL receptor expression.
Medicine Strength
75 mg
All Active Ingredients
Aspirin75 mg
Clopidogrel75 mg
Rosuvastatin20 mg
Uses & Benefits
Medical applications
Cholesterol
Xoten CA 75mg/20mg/75mg Tablet is a combination pharmaceutical formulation containing Aspirin (75mg), Rosuvastatin (20mg), and Clopidogrel (75mg), indicated for the prevention and management of cardiovascular diseases. Aspirin, an antiplatelet agent, inhibits cyclooxygenase, thereby reducing thromboxane A2 production and platelet aggregation, which helps prevent arterial thrombosis.
Read full descriptionShow less
Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) and triglycerides while modestly increasing high-density lipoprotein cholesterol (HDL-C), contributing to the reduction of atherosclerotic plaque progression. Clopidogrel, another antiplatelet agent, selectively inhibits the ADP receptor on platelet cell membranes, preventing platelet activation and aggregation.
The combined action of these agents provides a synergistic effect in reducing the risk of myocardial infarction, stroke, and other thrombotic cardiovascular events in patients with established coronary artery disease or at high risk of such conditions. Xoten CA is typically prescribed as part of a comprehensive cardiovascular risk management strategy, including lifestyle modification and other pharmacotherapies.
Caution is advised in patients with bleeding disorders, hepatic impairment, or hypersensitivity to any component. Regular monitoring of liver function, lipid profile, and bleeding parameters is recommended during therapy.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
Customer Reviews
0 reviews for Xoten CA 75mg/20mg/75mg Tablet
